Research
Teaching
Innovation

Vascular risk

Researchers

  • Asunción Ávila

    Vascular risk

    Phd

  • Luis Miguel Ceresuela

    Vascular risk

  • Manuel Jesús Gómez-choco

    Vascular risk

    Phd

  • Montserrat Martín-baranera

    Vascular risk

    Phd

  • Pedro Armario

    Vascular risk

    Phd

  • Peter Blanch

    Vascular risk

    Phd

  • Rachel Hernandez

    Vascular risk

    Phd

Contact the group

Form

  • De la Sierra A, Pareja J, Armario P, Barrera Á, Yun S, Vázquez S, Sans L, Pascual J, Oliveras A. 1354

    Renal Denervation vs. Spironolactone in Resistant Hypertension: Effects on Circadian Patterns and Blood Pressure Variability

    Am J Hypertens. 2017;30(1):37-41

  • Prats-Sanchez L, Martínez-Domeño A, Camps-Renom P, Delgado-Mederos R, Guisado-Alonso D, Marín R, Dorado L, Rudilosso S, Gómez-González A, Purroy F, Gómez-Choco M, Cánovas D, Cocho D, Garces M, Abilleira S, Martí-Fàbregas J. 1419

    Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis

    PLoS One. 2017; 12(6): e0178284. Published online 2017 Jun 22
    DOI

  • de la Sierra A, Pareja J, Fernández-Llama P, Armario P, Yun S, Acosta E, Calero F, Vázquez S, Blanch P, Sierra C, Oliveras A. 1394

    Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure.

    J Hypertens. 2017 Oct;35(10):2000-2005

  • Blanch P, Armario P, Oliveras A, Fernández-Llama P, Vázquez S, Pareja J, Álvarez E, Calero F, Sierra C, de la Sierra A. 1/18

    Association of Either Left Ventricular Hypertrophy or Diastolic Dysfunction With 24-Hour Central and Peripheral Blood Pressure

    Am J Hypertens. 2018;31(12):1293-1299

  • Gómez-Choco M, Mengual JJ, Rodríguez-Antigüedad J, Paré-Curell M, Purroy F, Palomeras E, Fuentes B, Ustrell X, Tembl J, Rodríguez-Yañez M, Castellanos M, Martí-Fabregas J, Serena J. 101 /19

    Pre-Existing Cerebral Small Vessel Disease Limits Early Recovery in Patients with Acute Lacunar Infarct

    J Stroke Cerebrovasc Dis. 2019;28(11):104312

Projects

    • Year 2020
    • HSDMB

    Study of factors influencing thrombolytic treatment in patients with minor stroke.

    • DISTRICT ATTORNEY:

      Dr. Manuel Gómez Choco

    • TYPE E:

      PINE TREE

    • Year 2020
    • HSDMB

    Remote ischemic conditioning in patients with acute ischemic stroke in Catalonia (REMOTE-CAT).

    • DISTRICT ATTORNEY:

      Dr. Francesc Purroy García - Foundation Dr. Pifarré–Institute for Biomedical Research of Lleida (IRBLleida)

    • TYPE E:

      P.S

  • Vascular risk

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Radiological and hemodynamic characteristics of lacunar strokes depending on their location.

    • DISTRICT ATTORNEY:

      Manuel Gómez Choco

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Analysis of the prognostic significance of the location and size of the infarct
    in patients with ischemic stroke.

    • DISTRICT ATTORNEY:

      Dr. Xabier Urra Nuin from the Neurology Service of the Hospital Clínic de Barcelona

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    International phase 2, randomized, double-blind, placebo-controlled, dose-response-matched study of BMS-986177, an oral factor XIa inhibitor, for the prevention of a new case of ischemic stroke or re- silent cerebral infarction in patients treated with aspirin and clopidogrel after an acute ischemic stroke or a transient ischemic attack (TIA).

    • DISTRICT ATTORNEY:

      Bristol-Myers Squibb Research and Development

    • TYPE E:

      RD2015

  • Vascular risk

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Benefits of early admission to a tertiary care center for patients with intracerebral hemorrhage. Multicentric and population study.

    • DISTRICT ATTORNEY:

      Research Institute of the Hospital de la Santa Creu i SantPau – IIB Sant Pau

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2019
    • Hospital General de l'Hospitalet

    Monitoring the Mobility of Parkinson's patients with therapeutic purposes - Clinical Trial.

    • DISTRICT ATTORNEY:

      Consorcio Sanitari del Garraf

    • TYPE E:

      PS

  • Vascular risk

    Researcher
    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Study of Alzheimer's disease biomarkers in the cerebrospinal fluid of patients with cognitive impairment in the Integral Health Consortium,

    • DISTRICT ATTORNEY:

      Asunción Ávila

    • TYPE E:

      PI

  • Vascular risk

    Researcher
    • Year 2019
    • Hospital General de l'Hospitalet

    Observational, prospective, multinational, multicenter study comparing the effectiveness of Safinamide, Rasagiline and other standard treatments as complementary treatment to Levadopa (L-dopa) in patients with fluctuating Parkinson's disease (PD).

    • DISTRICT ATTORNEY:

      Zambon S.p.A

    • TYPE E:

      EPA-SP

    • Year 2019
    • Sant Joan Despí Moisès Broggi Hospital

    Benefits of early admission to a tertiary care center for patients with intracerebral hemorrhage. Multicentric and population study.

    • DISTRICT ATTORNEY:

      Research Institute of the Hospital de la Santa Creu i SantPau – IIB Sant Pau

    • TYPE E:

      PINE TREE

Lines of action

  • Resistant hypertension and refractory hypertension
  • Arterial stiffness in hypertension and cerebrovascular disease
  • Small vessel cerebrovascular disease: Lacunar infarction
  • Factors associated with stroke recurrences
  • Thrombolytic treatment and acute stroke care circuits
  • Prognostic value of premorbid BP and BP in the acute phase of stroke

Documents

Information of interest

Links

Accessibility by WAH